In CD39-transgenic mice subjected to cerebral ischemia, CD39 overexpression attenuates cerebral ischemic injury, as evidenced by decreased leukocyte infiltration, reduced infarct sizes, and improved neurological deficits [228]. The gene discussed is ENTPD1; the disease is brain ischemia.